Literature DB >> 26216834

Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences.

Heather E King1, Alison Wakeford2, William Taylor2, Bradley Wetzell2, Kenner C Rice3, Anthony L Riley2.   

Abstract

Synthetic cathinones, otherwise known as "bath salts", have gained significant attention in the last few years as a result of increased use and abuse. One such compound, 3,4-methylenedioxypyrovalerone (MDPV), is pharmacologically and behaviorally similar to cocaine and has been shown to possess both aversive and rewarding effects. For a host of other drugs, each of these effects (and their relative balance) can be influenced by a variety of factors, including sex, which in turn impacts drug taking behavior. In this context, the present assessment sought to determine whether males and females differed in MDPV-induced CTA and CPP. Both male and female Sprague-Dawley rats underwent a combined CTA/CPP procedure, in which an injection of one of three doses of MDPV (1.0, 1.8 or 3.2mg/kg) was paired with both a novel saccharin solution and a novel environment and changes in preferences for these stimuli were examined. Taste avoidance was evident in both sexes, although this avoidance was weaker in females compared to males. MDPV also produced place preferences in all drug-treated animals, but these preferences did not vary as a function of sex. The fact that females showed a weaker avoidance response compared to males (despite comparable preferences) suggests that females may have a heightened susceptibility to use and abuse of MDPV, paralleling results seen with cocaine and other stimulants. The present findings extend the behavioral characterization of MDPV and the factors that may alter its aversive and rewarding effects.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MDPV; Place preference; Sex differences; Taste avoidance

Mesh:

Substances:

Year:  2015        PMID: 26216834      PMCID: PMC5548123          DOI: 10.1016/j.pbb.2015.07.013

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  52 in total

Review 1.  How to recognize a patient who's high on "bath salts".

Authors:  Thomas M Penders
Journal:  J Fam Pract       Date:  2012-04       Impact factor: 0.493

2.  Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.

Authors:  Laurie H L Sellings; Golriz Baharnouri; Lindsey E McQuade; Paul B S Clarke
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

3.  A history of morphine-induced taste aversion learning fails to affect morphine-induced place preference conditioning in rats.

Authors:  Heather E King; Anthony L Riley
Journal:  Learn Behav       Date:  2013-12       Impact factor: 1.986

Review 4.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

5.  Sex differences in the conditioned rewarding effects of cocaine.

Authors:  Scott J Russo; Shirzad Jenab; Sosimo J Fabian; Eugene D Festa; Lynne M Kemen; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2003-04-25       Impact factor: 3.252

Review 6.  Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?

Authors:  Suzette M Evans; Richard W Foltin
Journal:  Horm Behav       Date:  2009-09-04       Impact factor: 3.587

7.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

8.  Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats.

Authors:  M Gaiardi; M Bartoletti; A Bacchi; C Gubellini; M Costa; M Babbini
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Cocaine-induced conditioned taste aversions in rats.

Authors:  A J Goudie; D W Dickins; E W Thornton
Journal:  Pharmacol Biochem Behav       Date:  1978-06       Impact factor: 3.533

Review 10.  Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models.

Authors:  Nicole L Schramm-Sapyta; Q David Walker; Joseph M Caster; Edward D Levin; Cynthia M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  2009-06-23       Impact factor: 4.530

View more
  19 in total

1.  Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.

Authors:  Harmony I Risca; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2018-12-15       Impact factor: 4.530

2.  Conditioned taste avoidance, conditioned place preference and hyperthermia induced by the second generation 'bath salt' α-pyrrolidinopentiophenone (α-PVP).

Authors:  Katharine H Nelson; Briana J Hempel; Matthew M Clasen; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2017-04-17       Impact factor: 3.533

3.  Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats.

Authors:  Michael D Berquist; Lisa E Baker
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

4.  Sex differences in α-pyrrolidinopentiophenone (α-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats.

Authors:  Katharine H Nelson; Hayley N Manke; Aikerim Imanalieva; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2019-08-21       Impact factor: 3.533

5.  Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.

Authors:  Ryan A Gregg; Callum Hicks; Sunil U Nayak; Christopher S Tallarida; Paul Nucero; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2016-04-13       Impact factor: 5.250

Review 6.  Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).

Authors:  Richard A Glennon; Richard Young
Journal:  Brain Res Bull       Date:  2016-04-29       Impact factor: 4.077

7.  Detrimental effects of the 'bath salt' methylenedioxypyrovalerone on social play behavior in male rats.

Authors:  Sara Schiavi; Francesca Melancia; Emilia Carbone; Valeria Buzzelli; Antonia Manduca; Patricia Jiménez Peinado; Clemens Zwergel; Antonello Mai; Patrizia Campolongo; Louk J M J Vanderschuren; Viviana Trezza
Journal:  Neuropsychopharmacology       Date:  2020-06-07       Impact factor: 7.853

8.  Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).

Authors:  Callum Hicks; Ryan A Gregg; Sunil U Nayak; Lee Anne Cannella; Giana J Schena; Christopher S Tallarida; Allen B Reitz; Garry R Smith; Scott M Rawls
Journal:  Psychopharmacology (Berl)       Date:  2017-03-01       Impact factor: 4.530

9.  Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.

Authors:  Claudia J Woloshchuk; Katharine H Nelson; Kenner C Rice; Anthony L Riley
Journal:  Drug Alcohol Depend       Date:  2016-08-07       Impact factor: 4.492

10.  Synthetic cathinone self-administration in female rats modulates neurotransmitter levels in addiction-related brain regions.

Authors:  Julie A Marusich; Elaine A Gay; Scott L Watson; Bruce E Blough
Journal:  Behav Brain Res       Date:  2019-09-04       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.